Cosciens Biopharma Q4 EPS $(0.69) Up From $(2.15) YoY, Sales $1.766M Down From $3.300M YoY

Benzinga Newsdesk www.benzinga.com Negative 94.4%

Neg 94.4% Neu 0% Pos 0%

Cosciens Biopharma (OTC:CSCIF) reported quarterly losses of $(0.69) per share. This is a 67.91 percent increase over losses of $(2.15) per share from the same period last year. The company reported $1.766 million in sales this quarter. This is a 46.48 percent decrease over sales of $3.300 million the same period last year.